Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)

We believe in continuous discovery, improvement and creativity; that’s why we invest annually in our R&D labs to bring the state-of-the-art equipment for the formulation, characterization and analytical activities.

R&D team serves in two major trends:
The Productive trend which is exhibited in all lab-scale trials and scale-up activities of all pharmaceutical dosage forms, as well as The Responsive trend, manifested in troubleshooting of production, non-conforming reports and stability problems.
R&D team activities: 
These aim at establishing batch records for the new products and the existing products when needed, as well as evaluation and follow up of the first three batches and issuing the reports and protocols that are to be adopted by the Quality Assurance Section. 
R&D team, combining the scientific-talented pharmacists and the well-equipped facilities, is the spearhead of our company to maintain a cutting edge performance in nowadays fierce competition and to keep up with the era of global progress and sustainable developments.
R&D section has been developed to include equipment for production tests that are similar to those performed in the Production Sector, the matter which contributes to the success of the constant development operations.



Find out more


Quality Assurance 

EIPICO has been accredited ISO Certificates besides Certificates from European, African, and Asian Health Authorities. 

Read more
 




Quality Control

We support our incoming raw materials, packaging materials and products with timely and accurate test results, that meet the most recently issued pharmacopoeial references.

Read more




Regulatory Affairs 

The Regulatory Affairs assures company compliance with regulations and laws pertaining to development, manufacturing and marketing of all products.

Read more






WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1331146